OncoCyte Corporation

NASDAQ: OCX · Real-Time Price · USD
3.20
0.47 (17.22%)
At close: Jun 17, 2025, 3:59 PM

OncoCyte Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
PE Ratio
-0.51 -0.69 -0.48 -3.01
PEG Ratio
-0.02 0.01 0.06 -0.05
PS Ratio
16.54 12.73 37.13 24.97
PB Ratio
-2.53 0.75 1.04 2.96
P/FCF Ratio
-1.47 -0.81 -0.71 -5.05
P/OCF Ratio
-1.5 -0.82 -0.78 -5.37
OCF/S Ratio
-11.01 -15.52 -47.57 -4.65
Debt / Equity Ratio
-0.3 0.11 0.10 0.09
Quick Ratio
1.56 1.49 1.93 2.75
Current Ratio
1.62 1.49 2.11 2.77
Asset Turnover
0.05 0.02 0.01 0.05
Interest Coverage
-726.68 -483.38 -216.83 -224.62
Return on Equity
4.94 -1.09 -2.14 -0.98
Return on Assets
-1.73 -0.37 -0.73 -0.4
Return on Invested Capital
-2.1 -0.37 -0.2 -0.28
Dividend Yield
n/a n/a n/a n/a
Payout Ratio
n/a n/a n/a n/a
Gross Profit Margin
0.39 0.27 -0.02 0.02
Net Profit Margin
-32.25 -18.48 -76.66 -8.3
Pretax Profit Margin
-32.25 -16.54 -19.43 -9.49
Operating Profit Margin
-32.45 -16.72 -18.79 -6.08
FCF Margin
n/a n/a n/a n/a
EBITDA Margin
-31.37 -15.38 -13.9 -6.27